LivaNova PLC (LIVN) Offers Update Following FDA Warning Letter
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
LivaNova PLC Provides Update on FDA Warning Letter
January 5, 2016 2:15 PM ESTLONDON, Jan. 05, 2016 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ: LIVN) (LSE: LIVN) (the Company) received a Warning Letter dated December 29, 2015, from the United States Food and Drug Administration (FDA) alleging certain violations of FDA regulations applicable to medical device manufacturers at its Munich, Germany and Arvada, Colorado facilities.
The Company currently believes that less than 1 percent of 2016 consolidated sales could be impacted by this Warning Letter, and that FDAs concerns can be resolved without a material impact on the Companys financial results. Â Further... More
